Welcome to CDC stacks | High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium - 49594 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium
  • Published Date:
    Nov 2017
  • Source:
    Emerg Infect Dis. 23(11):1902-1904.
Filetype[PDF-491.51 KB]


Details:
No Related Documents.
You May Also Like:
  1. Emergence of vancomycin-resistant enterococci.
    Personal Author:
    Rice, L. B.
    Published:
    2001 Mar-Apr
    Source:
    Emerg Infect Dis. 7(2):183-187.
    Description:
    Vancomycin and ampicillin resistance in clinical Enterococcus faecium strains has developed in the past decade. Failure to adhere to strict infection control to prevent the spread of these pathogens has been well established. New data implicate the u...
    File Type:
    Filetype[PDF - 61.72 KB]
  2. Diversity among multidrug-resistant enterococci.
    Personal Author:
    Murray, B. E.
    Published:
    1998 Jan-Mar
    Source:
    Emerg Infect Dis. 4(1):37-47.
    Description:
    Enterococci are associated with both community- and hospital-acquired infections. Even though they do not cause severe systemic inflammatory responses, such as septic shock, enterococci present a therapeutic challenge because of their resistance to a...
    File Type:
    Filetype[PDF - 66.33 KB]
  3. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe.
    Personal Author:
    Wegener, H. C.; Aarestrup, F. M.; Jensen, L. B.; Hammerum, A. M.; Bager, F.;
    Published:
    1999 May-Jun
    Source:
    Emerg Infect Dis. 5(3):329-335.
    Description:
    Supplementing animal feed with antimicrobial agents to enhance growth has been common practice for more than 30 years and is estimated to constitute more than half the total antimicrobial use worldwide. The potential public health consequences of thi...
    File Type:
    Filetype[PDF - 85.14 KB]
  4. Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium
    Personal Author:
    Leavis, Helen L.; Willems, Rob J.L.; Top, Janetta; Spalburg, Emile; Mascini, Ellen M.; Fluit, Ad C.; Hoepelman, Andy; de Neeling, Albert J.; Bonten, Marc J.M.;
    Published:
    Sep 2003
    Source:
    Emerg Infect Dis. 9(9):1108-1115.
    Description:
    The epidemiology of vancomycin-resistant Entero- coccus faecium (VREF) in Europe is characterized by a large community reservoir. In contrast, nosocomial outbreaks and infections (without a community reservoir) characterize VREF in the United States....
    File Type:
    Filetype[PDF - 454.62 KB]
  5. First Characterization of a Cluster of VanA-Type Glycopeptide-Resistant Enterococcus faecium, Colombia
    Personal Author:
    Panesso, Diana; Ospina, Sigifredo; Robledo, Jaime; Vela, María Claudia; Peña, Julieta; Hernández, Orville; Reyes, Jinnethe; Arias, César A.;
    Published:
    Sep 2002
    Source:
    Emerg Infect Dis. 8(9):961-965.
    Description:
    From August 1998 to October 1999, glycopeptide-resistant enterococci (GRE) were isolated from 23 infected patients at a teaching hospital in Medellín, Colombia. Identification at the species level and by multiplex polymerase chain reaction assay ind...
    File Type:
    Filetype[PDF - 353.90 KB]